Sign In
Buy PROK
$1.73
-0.170 (-8.95%)
At Close: Jun 03, 2026
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
07:49pm, Thursday, 21'st Mar 2024
WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chro
ProKidney to Participate in Jefferies Biotech on the Bay Summit
04:05pm, Thursday, 29'th Feb 2024
WINSTON-SALEM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease
Here's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Now
11:17am, Wednesday, 13'th Dec 2023
ProKidney Corp. (PROK) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could me
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer
06:05am, Thursday, 30'th Nov 2023
Former CEO of Africa Healthcare Network brings extensive understanding of kidney disease to ProKidney Former CEO of Africa Healthcare Network brings extensive understanding of kidney disease to ProKid
7 Penny Stocks With Low Floats and High Short Interest
06:40am, Friday, 24'th Nov 2023
There are many ways to approach penny stocks, but one that has gained popularity in recent years focuses on stocks in this category that are prime candidates for a “short squeeze.” A typical short
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference
06:05am, Tuesday, 21'st Nov 2023
WINSTON-SALEM, N.C, Nov. 21, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on pres
ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript
04:40pm, Thursday, 16'th Nov 2023
ProKidney Corp. (NASDAQ:PROK ) Q3 2023 Results Conference Call November 14, 2023 8:00 AM ET Company Participants Dr. Glenn Schulman - SVP of IR Pablo Legorreta - Chairman of Board Dr. Tim Bertram - Co
After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK)
11:17am, Thursday, 16'th Nov 2023
The heavy selling pressure might have exhausted for ProKidney Corp. (PROK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana
ProKidney Reports Third Quarter Financial Results
06:05am, Tuesday, 14'th Nov 2023
WINSTON-SALEM, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (
Updated positive interim Phase 2 data demonstrate potential efficacy of REACT® to preserve kidney function in moderate and high-risk diabetic CKD patients
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023
04:12pm, Monday, 30'th Oct 2023
Total of 6 abstracts accepted for publication in Kidney Week 2023 program Total of 6 abstracts accepted for publication in Kidney Week 2023 program
ProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:19am, Tuesday, 17'th Oct 2023
ProKidney Corp. (PROK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings est
Is Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock?
02:50pm, Monday, 16'th Oct 2023
Shares of ProKidney (NASDAQ: PROK ) are in the green today, despite recent sales from special purpose acquisition company (SPAC) sponsor Chamath Palihapitiya. Back in July of 2022, ProKidney agreed to
Why Shares of ProKidney Were Dropping Thursday
03:05pm, Thursday, 12'th Oct 2023
ProKidney focuses on therapies to treat chronic kidney disease (CKD). One of its top shareholders sold roughly $1.23 million worth of company stock.
Short squeeze alert for September 27th: 2 stocks that could skyrocket
09:38am, Wednesday, 27'th Sep 2023
Stock market investors are regularly monitoring highly shorted stocks, as the potential for an abrupt surge looms large.
